Country, language and currency
- Social bookmarks:
- Testimonials
-
Dear Sir,
The order placed on the 19-05-2006 was delivered within 7 days, a most
impressive service.
Be assured that when I decide to place further orders I will contact you
again, and will inform my friends of your excellent service.
Many thanks
- Brian
Read more »
-
- Actavis wins FDA approval for Ropinirole extended-release tablets - Pharmaceutical Business Review
- Actavis wins FDA approval for Ropinirole extended-release tabletsPharmaceutical Business ReviewActavis Group, a generic pharmaceuticals company, has gained FDA approval for Ropinirole extended-release tablets, 2mg, 4mg, 6mg, 8mg and 12mg
- Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended ... - MarketWatch (press release)
- Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended
- Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip - The Pharma Letter
- Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic RequipThe Pharma LetterSeparately, Switzerland headquartered Actavis Group, which is currently the subject of a 4
- NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights - MarketWatch (press release)
- NuPathe Announces First Quarter 2012 Financial Results and Operational HighlightsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery
- Safeguard Scientifics Announces First Quarter 2012 Financial Results - MarketWatch (press release)
- Safeguard Scientifics Announces First Quarter 2012 Financial ResultsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery
